CytomX Therapeutics (CTMX) PT Raised to $3.20 at BMO Capital
Tweet
Share
E-mailGet Alerts CTMX Hot Sheet
Price: $3.36 +0.30%
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
BMO Capital analyst Etzer Darout raised the price target on CytomX Therapeutics (NASDAQ: CTMX) to $3.20 (from $2.60) while maintaining a Market Perform rating.
You May Also Be Interested In
- CytomX Therapeutics (CTMX) PT Lowered to $14 at Guggenheim
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
- Indigo Paints (INDIGOPN:IN) PT Raised to INR1,300 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
